TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma

Cell

Volumn 160, Issue 5, 2015, Pages 963-976

  Oshimori, Naoki ^a   Oristian, Daniel ^a   Fuchs, Elaine ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GLUTATHIONE; PROTEIN P21; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; 7,12 DIMETHYLBENZ[A]ANTHRACENE; NFE2L2 PROTEIN, HUMAN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; GLUTATHIONE METABOLISM; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR INVASION; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMAN; METABOLISM; NUDE MOUSE; SKIN NEOPLASMS; XENOGRAFT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GLUTATHIONE; HEAD AND NECK NEOPLASMS; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NF-E2-RELATED FACTOR 2; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84923329516     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.01.043     Document Type: Article

References (52)

1. B. Beck, G. Driessens, S. Goossens, K.K. Youssef, A. Kuchnio, A. Caauwe, P.A. Sotiropoulou, S. Loges, G. Lapouge, and A. Candi A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours Nature 478 2011 399 403
2. A. Berns Stem cells for lung cancer? Cell 121 2005 811 813
3. S. Beronja, G. Livshits, S. Williams, and E. Fuchs Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos Nat. Med. 16 2010 821 827
4. C.L. Bigarella, R. Liang, and S. Ghaffari Stem cells and the impact of ROS signaling Development 141 2014 4206 4218
5. S. Boumahdi, G. Driessens, G. Lapouge, S. Rorive, D. Nassar, M. Le Mercier, B. Delatte, A. Caauwe, S. Lenglez, and E. Nkusi SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma Nature 511 2014 246 250
6. A. Bruna, R.S. Darken, F. Rojo, A. Ocaña, S. Peñuelas, A. Arias, R. Paris, A. Tortosa, J. Mora, J. Baselga, and J. Seoane High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene Cancer Cell 11 2007 147 160
7. C.R. Chen, Y. Kang, P.M. Siegel, and J. Massagué E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression Cell 110 2002 19 32
8. W. Chen, Z. Sun, X.-J. Wang, T. Jiang, Z. Huang, D. Fang, and D.D. Zhang Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response Mol. Cell 34 2009 663 673
9. L. Chin, A. Tam, J. Pomerantz, M. Wong, J. Holash, N. Bardeesy, Q. Shen, R. O'Hagan, J. Pantginis, and H. Zhou Essential role for oncogenic Ras in tumour maintenance Nature 400 1999 468 472
10. W. Cui, D.J. Fowlis, S. Bryson, E. Duffie, H. Ireland, A. Balmain, and R.J. Akhurst TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice Cell 86 1996 531 542
11. R. Derynck, and K. Miyazono The TGF-β family 2008 Cold Spring Harbor Laboratory Press Woodbury, New York
12. M. Diehn, R.W. Cho, N.A. Lobo, T. Kalisky, M.J. Dorie, A.N. Kulp, D. Qian, J.S. Lam, L.E. Ailles, and M. Wong Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 2009 780 783
13. R.R. Gomis, C. Alarcón, C. Nadal, C. Van Poznak, and J. Massagué C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells Cancer Cell 10 2006 203 214
14. C. Gorrini, I.S. Harris, and T.W. Mak Modulation of oxidative stress as an anticancer strategy Nat. Rev. Drug Discov. 12 2013 931 947
15. M. Greaves, and C.C. Maley Clonal evolution in cancer Nature 481 2012 306 313
16. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
17. G.R. Grotendorst, G. Smale, and D. Pencev Production of transforming growth factor β by human peripheral blood monocytes and neutrophils J. Cell. Physiol. 140 1989 396 402
18. G. Guasch, M. Schober, H.A. Pasolli, E.B. Conn, L. Polak, and E. Fuchs Loss of TGFβ signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia Cancer Cell 12 2007 313 327
19. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
20. K.J. Hope, L. Jin, and J.E. Dick Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity Nat. Immunol. 5 2004 738 743
21. H. Ijichi, A. Chytil, A.E. Gorska, M.E. Aakre, Y. Fujitani, S. Fujitani, C.V.E. Wright, and H.L. Moses Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression Genes Dev. 20 2006 3147 3160
22. L. Kelland The resurgence of platinum-based cancer chemotherapy Nat. Rev. Cancer 7 2007 573 584
23. D. Koinuma, S. Tsutsumi, N. Kamimura, H. Taniguchi, K. Miyazawa, M. Sunamura, T. Imamura, K. Miyazono, and H. Aburatani Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor β signaling Mol. Cell. Biol. 29 2009 172 186
24. A. Kreso, and J.E. Dick Evolution of the cancer stem cell model Cell Stem Cell 14 2014 275 291
25. G. Lapouge, B. Beck, D. Nassar, C. Dubois, S. Dekoninck, and C. Blanpain Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness EMBO J. 31 2012 4563 4575
26. S.-L. Lu, H. Herrington, D. Reh, S. Weber, S. Bornstein, D. Wang, A.G. Li, C.-F. Tang, Y. Siddiqui, and J. Nord Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma Genes Dev. 20 2006 1331 1342
27. V.I. Lushchak Glutathione homeostasis and functions: potential targets for medical interventions J. Amino Acids 2012 2012 736837
28. I. Malanchi, H. Peinado, D. Kassen, T. Hussenet, D. Metzger, P. Chambon, M. Huber, D. Hohl, A. Cano, W. Birchmeier, and J. Huelsken Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling Nature 452 2008 650 653
29. J. Massagué TGFβ signalling in context Nat. Rev. Mol. Cell Biol. 13 2012 616 630
30. J. Massagué, J. Seoane, and D. Wotton Smad transcription factors Genes Dev. 19 2005 2783 2810
31. C.E. Meacham, and S.J. Morrison Tumour heterogeneity and cancer cell plasticity Nature 501 2013 328 337
32. A.C. Mullen, D.A. Orlando, J.J. Newman, J. Lovén, R.M. Kumar, S. Bilodeau, J. Reddy, M.G. Guenther, R.P. DeKoter, and R.A. Young Master transcription factors determine cell-type-specific responses to TGF-β signaling Cell 147 2011 565 576
33. N.M. Muñoz, M. Upton, A. Rojas, M.K. Washington, L. Lin, A. Chytil, E.G. Sozmen, B.B. Madison, A. Pozzi, and R.T. Moon Transforming growth factor β receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation Cancer Res. 66 2006 9837 9844
34. R. Nischt, D.R. Roop, T. Mehrel, S.H. Yuspa, M. Rentrop, H. Winter, and J. Schweizer Aberrant expression during two-stage mouse skin carcinogenesis of a type I 47-kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia Mol. Carcinog. 1 1988 96 108
35. F. Notta, S. Doulatov, E. Laurenti, A. Poeppl, I. Jurisica, and J.E. Dick Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment Science 333 2011 218 221
36. N. Oshimori, and E. Fuchs The harmonies played by TGF-β in stem cell biology Cell Stem Cell 11 2012 751 764
37. N. Oshimori, and E. Fuchs Paracrine TGF-β signaling counterbalances BMP-mediated repression in hair follicle stem cell activation Cell Stem Cell 10 2012 63 75
38. M. Schober, and E. Fuchs Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling Proc. Natl. Acad. Sci. USA 108 2011 10544 10549
39. J. Seoane, H.-V. Le, L. Shen, S.A. Anderson, and J. Massagué Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation Cell 117 2004 211 223
40. J.M. Siegle, A. Basin, A. Sastre-Perona, Y. Yonekubo, J. Brown, R. Sennett, M. Rendl, A. Tsirigos, J.A. Carucci, and M. Schober SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma Nat. Commun. 5 2014 4511
41. S. Thuault, U. Valcourt, M. Petersen, G. Manfioletti, C.-H. Heldin, and A. Moustakas Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition J. Cell Biol. 174 2006 175 183
42. J.E. Visvader, and J. Stingl Mammary stem cells and the differentiation hierarchy: current status and perspectives Genes Dev. 28 2014 1143 1158
43. Y. Yamashiro, K. Takei, M. Umikawa, T. Asato, M. Oshiro, Y. Uechi, T. Ishikawa, K. Taira, H. Uezato, and K. Kariya Ectopic coexpression of keratin 8 and 18 promotes invasion of transformed keratinocytes and is induced in patients with cutaneous squamous cell carcinoma Biochem. Biophys. Res. Commun. 399 2010 365 372
44. S. Dennler, S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J.M. Gauthier Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene EMBO J. 17 1998 3091 3100
45. A. Ertürk, K. Becker, N. Jährling, C.P. Mauch, C.D. Hojer, J.G. Egen, F. Hellal, F. Bradke, M. Sheng, and H.U. Dodt Three-dimensional imaging of solvent-cleared organs using 3DISCO Nat. Protoc. 7 2012 1983 1995
46. G.S. Filonov, K.D. Piatkevich, L.M. Ting, J. Zhang, K. Kim, and V.V. Verkhusha Bright and stable near-infrared fluorescent protein for in vivo imaging Nat. Biotechnol. 29 2011 757 761
47. P. Levéen, J. Larsson, M. Ehinger, C.M. Cilio, M. Sundler, L.J. Sjöstrand, R. Holmdahl, and S. Karlsson Induced disruption of the transforming growth factor β type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable Blood 100 2002 560 568
48. S. Srinivas, T. Watanabe, C.S. Lin, C.M. William, Y. Tanabe, T.M. Jessell, and F. Costantini Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus BMC Dev. Biol. 1 2001 4
49. A.L. Szymczak-Workman, K.M. Vignali, and D.A.A. Vignali Design and construction of 2A peptide-linked multicistronic vectors Cold Spring Harb Protoc 2012 2012 199 204
50. C. Trapnell, B.A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M.J. van Baren, S.L. Salzberg, B.J. Wold, and L. Pachter Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation Nat. Biotechnol. 28 2010 511 515
51. C. Trapnell, A. Roberts, L. Goff, G. Pertea, D. Kim, D.R. Kelley, H. Pimentel, S.L. Salzberg, J.L. Rinn, and L. Pachter Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks Nat. Protoc. 7 2012 562 578
52. V. Vasioukhin, L. Degenstein, B. Wise, and E. Fuchs The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin Proc. Natl. Acad. Sci. USA 96 1999 8551 8556